| Specific Topics of Lobbying Communications |
Intended Outcomes |
Associated Subject Matters |
Communicating with government officials about improvements to approval processes for pharmaceuticals, including (i) streamlining rare disease drug review processes and (ii) harmonizing clinical trials and research ethics reviews.
|
-
Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity
|
Health
|
Communicating with government officials about policies and programs designed to support innovative research and development in the pharmaceutical sector.
|
-
Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity
|
Health
|
|